BDBM195905 US9206188, 148::US9834551, Example 148

SMILES Cc1cccc(-c2c[nH]c3ncc(cc23)-c2cccc(NC(=O)C=C)c2)c1F

InChI Key InChIKey=JEKGFKWIAUMDPD-UHFFFAOYSA-N

Data  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 195905   

TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Arrien Pharmaceuticals

US Patent
LigandPNGBDBM195905(US9206188, 148 | US9834551, Example 148)
Affinity DataIC50:  154nMAssay Description:1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Ja...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Arrien Pharmaceuticals

US Patent
LigandPNGBDBM195905(US9206188, 148 | US9834551, Example 148)
Affinity DataIC50:  7.56E+3nMAssay Description:1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Ja...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Arrien Pharmaceuticals

US Patent
LigandPNGBDBM195905(US9206188, 148 | US9834551, Example 148)
Affinity DataIC50:  72.4nMAssay Description:1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Ja...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Arrien Pharmaceuticals

US Patent
LigandPNGBDBM195905(US9206188, 148 | US9834551, Example 148)
Affinity DataIC50: <100nMAssay Description:ITK and JAK3 Kinase assay procedures:Enzyme was incubated with substrate peptide in reaction buffer in the presence and absence of test compounds or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Arrien Pharmaceuticals

US Patent
LigandPNGBDBM195905(US9206188, 148 | US9834551, Example 148)
Affinity DataIC50: <5nMAssay Description:1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Ja...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Arrien Pharmaceuticals

US Patent
LigandPNGBDBM195905(US9206188, 148 | US9834551, Example 148)
Affinity DataIC50: <100nMAssay Description:ITK and JAK3 Kinase assay procedures:Enzyme was incubated with substrate peptide in reaction buffer in the presence and absence of test compounds or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Arrien Pharmaceuticals

US Patent
LigandPNGBDBM195905(US9206188, 148 | US9834551, Example 148)
Affinity DataIC50: >1.00E+5nMAssay Description:1H-pyrrolo[2,3-b]pyridine, 1H-pyrazolo[3,4-b]pyridine and 5H-pyrrolo[2,3-b]pyrazine series of compounds exhibited over >100 fold selective against Ja...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent